Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Fresenius gets out of respiratory therapy

Industrial gas giant Linde has bought French homecare provider Calea. The company was part of Fresenius Kabi, the worldwide infusion/nutrition and transfusion business. The acquisition is one of several that have turned Linde into a serious player in the French oxygen market. Meanwhile, the German Federal Cartel Authority has approved Fresenius Kabi’s acquisition of US blood player Fenwal Holdings, which gives Fresenius Kabi a 33% share in blood donation in Germany.
December 17, 2012

Bergman plans massive growth

Bergman Clinics, the largest private ambulatory clinic chain in the Netherlands, plans to grow 2012 sales of €70m nearly four times to €250m by 2016. The group, owned by the Malenstein family and entrepreneur Jaap Maljers, is looking for an external investor to take a minority stake. We talk to Chief Executive Bart Malenstein and give an overview of the Dutch private clinic market.
December 14, 2012

FREE BLOG Perceptions of the NHS or what zebras think of lions

Last week a Labour MP, Ann Clywd, claimed that the NHS in Wales had treated her dying husband like a battery hen and castigated low levels of nursing care. The social media response has been fascinating, and will mark a profound change in how the NHS is perceived.
December 10, 2012

Korian launches bid worth €268m for Curanum

Listed French care home group Korian has launched a bid for German group Curanum, which Korian claims would make it the second-largest player in the German market. But will the bid succeed? And what does it tell us about the pan-European expansion of the big French groups?
December 10, 2012

French lab market looks less worried

The French lab market has been scared by reports that Health Minister Touraine is preparing for a shake-up of the sector - but is there really anything to fear?
December 7, 2012

Parsa quits Circle

In a surprise move, Ali Parsa has stepped down as chief executive of Circle Health. The UK hospital group won the first contract to functionally outsource an NHS hospital at Hinchingbrooke earlier in 2012. The new interim CEO is Steve Melton, currently head of mobilisation. Parsa will stay on as a non-executive.
December 7, 2012

Baxter swoops on Gambro

As predicted here, Baxter - the world’s largest peritoneal dialysis operator - has purchased Gambro, the second-largest player in haemodialysis in Europe, for SEK 26.5bn (€3.08bn) from EQT and Investor. The deal is seen as a way for Baxter to present itself as a "one-stop shop" to payors and providers, and to better compete with Fresenius, the world’s largest player in dialysis.
December 7, 2012

Radical reform to follow as Italy uncovers massive healthcare corruption

Accusations of corruption, inefficiencies and hidden agendas are rife in Italian healthcare. The president of Lazio region has been forced to step down following a scandal; the government of Lombardy, a key private-sector stronghold, has also been rocked by allegations. The media has hounded Mario Monti, forcing him to walk back pro-private sector statements. As a backdrop to all of this, Health Minister Renato Balduzzi’s spending cuts are ravaging the private hospital sector.
November 30, 2012

All change in dialysis

The dialysis sector looks certain to consolidate fast in Europe. Bankers say that Bridgepoint is keen to exit Diaverum, which it bought near the height of the boom in late 2007. Meanwhile, they also say that Baxter looks near certain to buy EQT-backed Gambro.
November 30, 2012
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us